Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2510]

Enzalutamide may offer chemotherapy alternative in metastatic castration-resistant prostate cancer

Enzalutamide may offer chemotherapy alternative in metastatic castration-resistant prostate cancer

Blood test could identify when cancer treatment has become detrimental

Blood test could identify when cancer treatment has become detrimental

New gene research helps pinpoint prostate cancer risk

New gene research helps pinpoint prostate cancer risk

$ASTRO: Prostate cancer patients who receive hypofractionated RT report consistent QoL$

ASTRO: Prostate cancer patients who receive hypofractionated RT report consistent QoL

ASTRO: Prostate cancer patients surveyed 5 years after vessel-sparing RT report preserved sexual function

ASTRO: Prostate cancer patients surveyed 5 years after vessel-sparing RT report preserved sexual function

ASTRO: Study identifies when and how much various prostate cancer treatments will impact urinary and sexual functioning

ASTRO: Study identifies when and how much various prostate cancer treatments will impact urinary and sexual...

International study identifies new genetic variants indicating risk for prostate cancer

International study identifies new genetic variants indicating risk for prostate cancer

Predicting prostate cancer: Test identifies new methods for treatment

Predicting prostate cancer: Test identifies new methods for treatment

New knowledge of genes driving bladder cancer points to targeted treatments

New knowledge of genes driving bladder cancer points to targeted treatments

New guideline on treating mCRPC

New guideline on treating mCRPC

More from ecancer